Actelion Settles Tracleer Antitrust Case For $65m Ahead Of Trial

Third-Party Payors Accused Firm Of Using REMS Restrictions To Block Generic Bosentan Competition

 
• By Dean Rudge
  
Settlement newspaper headline on money
• Source: Shutterstock

More from Legal & IP

More from Generics Bulletin